To view this email as a web page, click here.

 
Dermatology Times
Mycobiome impairs wound healing
Identifying the presence of bacterial and fungal species improves antimicrobial therapy, according to a recent review published in the July issue of Advances in Wound Care.
ADVERTISEMENT
 
Dermatology Times
Leg ulcers that require punch biopsies
Victor Desmond Mandel, M.D. and colleagues describe a reconstruction strategy for chronic infected neoplastic ulcers of the lower extremities using a dermal matrix and a unique postoperative dressing protocol.
ADVERTISEMENT
 
Dermatology Times
Protease targets in wound healing
Protease modulating therapies are used to assist in venous leg ulcer closure, but a recent review suggests that physicians should reexamine the biomarker's role in targeted chronic wound healing therapies.
ADVERTISEMENT
 
A guide to wound care
In this printable table, we cover the basics of wound care, such as reducing bioburden, reducing edema and maintaining a moist wound environment.
 
Psoriasis Resource Center
 
Biosimilars safety performance in psoriasis
Arthritis in psoriasis not as common as we once thought
An alternative way to adopt corticosteroids safely
 
From Our Latest Issue
 
Dermatology Times cover
Four effective anti-IL 23 drugs for psoriasis
 
Microneedling versus laser: Is one better than the other?
 
Opioid prescription post-surgical strategy
 
ADVERTISEMENT
“Approach every single acne patient as a patient who can potentially scar”
Approximately 40% of acne patients have scars — and scarring can occur in any severity of acne. Watch this video to learn more about how a decrease in acne lesions can lead to a decrease in acne scars, even in moderate to severe acne patients.
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
The Cosmetic Professional's Guide to Patient Financing
Would you like to grow your revenue while saving thousands in provider fees? Download the Ultimate Guide to Patient Financing to learn how! Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.